Home drugs Xalkori (Crizotinib)

Xalkori (Crizotinib)

This page contains brief information about crizotinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)       Xalkori
FDA Approved             Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Crizotinib is approved to treat:

  • Non-small cell lung cancer that has metastasized (spread to other parts of the body). It is used in patients whose cancer has a certain type of chromosomemutation that affects the anaplastic lymphoma kinase (ALK) gene or the ROS1 gene.

Crizotinib is also being studied in the treatment of other types of cancer.

More About Crizotinib

Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.

MedlinePlus Information on Crizotinib – A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.